Artos
YC W24San Francisco, US · Founded 2023 · 7 employees · Hiring · 5 known investors
Artos provides AI-powered software tools for Chemistry, Manufacturing, and Controls (CMC) teams in the pharmaceutical industry to draft, manage, and quality-check regulatory documentation. The platform uses specialized AI systems designed to handle dense tabular data and non-standard formats common in regulatory Module 3 documents.
Also known as Talos
AI & Machine LearningBiotechEnterprise SoftwareMedical DevicesUnited States of AmericaAmerica / Canada
Founders & leadership· Y Combinator alumni (W24)
Artos was founded in 2023 by Josh Kim and Varun Patel.
JK
VP
Varun PatelinFounderVarun Patel is a co-founder and CTO at Artos with a background in molecular engineering (University of Chicago) and translational medicine (UCSF/UC Berkeley). He previously worked as a software engineer developing machine learning applications for healthcare, including mobile tools for dementia caregivers and insurance infrastructure improvements.
Investors · 5
Images
Competitors · 6
by search overlapIktos6 shared keywordsIktos develops generative AI and robotics platforms for drug discovery, automating molecular design, synthesis planning, and biological testing. The company serves pharmaceutical and biotech organizations seeking to accelerate preclinical drug development.
Altos Labs4 shared keywordsAltos Labs develops computational and scientific approaches to reverse disease through breakthrough medicines, operating research institutes focused on cell health, computation, and drug discovery.
ACTO4 shared keywordsActo provides a mobile app platform for field-based sales teams in regulated industries to deliver training, coaching, and presentations with approved content and messaging. The solution includes keyword search, knowledge tracking via surveys, and push notification alerts for content updates.
Aetos Imaging3 shared keywordsAetos Imaging provides a visual management software built on digital scans of a customer's physical facility, used to manage, maintain, and train around building operations and assets. It serves energy and utilities, manufacturing, and other industrial and built-environment organizations.
Artios Pharma3 shared keywordsArtios develops DNA Damage Response (DDR)-based therapeutics for hard-to-treat solid tumors, including small-molecule inhibitors targeting ATR (alnodesertib) and DNA polymerase theta (ART6043). The company operates a proprietary DDR drug-development platform called DcoDeR and advances a pipeline of oncology product candidates through clinical trials.
Areto Labs3 shared keywordsAreto Labs offers a responsible AI platform that combines human judgment with AI to detect and filter harmful online content such as hate speech and technology-facilitated gender-based violence, helping global brands and public figures build safer digital communities. The women-owned Canadian company serves organizations across sectors including politics, sport, and media.
Companies competing with Artos for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Artos do?
- Artos provides AI-powered software tools for Chemistry, Manufacturing, and Controls (CMC) teams in the pharmaceutical industry to draft, manage, and quality-check regulatory documentation. The platform uses specialized AI systems designed to handle dense tabular data and non-standard formats common in regulatory Module 3 documents.
- Who founded Artos?
- Artos was founded by Josh Kim, Varun Patel in 2023.
- Who are Artos's investors?
- Artos's investors include Y Combinator, Horizon, MyAsiaVC, Antler, Socii Capital.
- Where is Artos headquartered?
- Artos is headquartered in San Francisco, US.